Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지

Utility of the BoneSource® in the Treatment of Craniofacial Bone Defect

두개안면골 결손 환자의 치료에서 Bonesource®의 유용성

  • Byeon, Jun Hee (Department of Plastic and Reconstructive Surgery, College of Medicine, The Catholic University of Korea) ;
  • Song, Jin Kyung (Department of Plastic and Reconstructive Surgery, College of Medicine, The Catholic University of Korea) ;
  • Yoo, Gyeol (Department of Plastic and Reconstructive Surgery, College of Medicine, The Catholic University of Korea)
  • 변준희 (가톨릭대학교 의과대학 성형외과학교실) ;
  • 송진경 (가톨릭대학교 의과대학 성형외과학교실) ;
  • 유결 (가톨릭대학교 의과대학 성형외과학교실)
  • Received : 2004.08.23
  • Published : 2005.01.10
Download PDF
⟨ Previous Next ⟩

Abstract

Skull or facial bone defect causes cosmetic and functional problems. On going efforts were taken to reconstruct the craniofacial bone defect with autogenous bone or alloplastic materials. Between 2001 and 2003, we reconstructed 15 cases with small to large craniofacial bone defect using Hydroxyapatite paste($BoneSource^{(R)}$, Leibinger Corp., Dallas, TX, U.S.A) and calvarial bone graft. All patients were followed up by clinical examination and periodic radiographic studies for an average of 1.6 years (range, 6 months to 2 years and 6 months). One complication case was noted with $BoneSource^{(R)}$ exposure. Otherwise, there was no evidence of adverse healing, wound infection, foreign body reaction and seroma collection in other patients. Adequate 3-dimensional aesthetic restoration of calvarial contour was noted in each case. In conclusion, $Bonesource^{(R)}$ is relatively safe and rigid material for craniofacial bone defect and reasonable method for the reconstruction of craniofacial bone defects.

Keywords

References

  1. Costantino PD, Friedman CD, Lane A: Synthetic biomaterials in facial plastic and reconstructive surgery. Facial Plastic Surg 9: 1, 1993 https://doi.org/10.1055/s-2008-1064591
  2. Yadranko D: Titanium mesl. and hydroxyapatite cement cranioplasty: A report of 20 cases. J Oral Maxillafac Surg 60: 272, 2002 https://doi.org/10.1053/joms.2002.30575
  3. Eric J, Douglas K: Hydroxyapatite paste(BoneSource) used as an onlay implant for supraorbital and malar augmentation. J Craniofac Surg 8: 367, 1997 https://doi.org/10.1097/00001665-199708050-00007
  4. Turk JB, Parhiscar A: BoneSource for craniomaxillofacial reconstruction. Facial Plastic Surg 16: 7, 2000 https://doi.org/10.1055/s-2000-7321
  5. Constantino PD, Friedman CD, Jones K: Experimental hydroxyapatite cement cranioplasty. Plast Reconstr Surg 90: 174, 1992 https://doi.org/10.1097/00006534-199290020-00003
  6. Verheggen R, Merten HA: Correction of skull defects using hydroxyapatite cerrent(HAq-Evidence derived from animal experiments and clinical experience. Acta Neurochir 143: 919, 2001 https://doi.org/10.1007/s007010170022
  7. Matic D, Phillips JH: A contraindication for the use of hydroxyapatite cement in the pediatric population. Plast Reconstr Surg 110(1): 1, 2002 https://doi.org/10.1097/00006534-200207000-00001
  8. Constantino PD, Chaplin JM, Wolpoe ME: Applications of fast setting hydroxyapatite cement: Cranioplasty. Oiolaryngol Head Neck Surg 3: 409, 2000